XORTX Therapeutics
XRTX | NASDAQ
$1.04
-$0.06 (-5.45%)
At close: Nov 16, 2026, 4:00 PM ET
$1.01
-$0.03 (-2.88%)
After-hours:
Nov 16, 2026, 7:57 PM ET
-5.45%
(1D)No price chart data available for 1D timeframe.
Rating
20.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #990/1021 (Top 97%)
Key Statistics
Market Data
Market Cap $1.89M
1D Range
0.97 1.44
52W Range
0.84 3.24
Valuation (TTM)
PE -0.45
PB 0.37
EV/EBITDA -0.46
Valuation (NTM)
Forward PE 0.25
Forward PEG 0.01
Price Target $0.00
Cash Flow
FCF Yield -65.2%
SBC Adj. FCF Yield -65.8%
SBC Impact -1.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -1281.5% |
-134.7%
FCF 3Y | 5Y 52.1% |
44.4%
Returns
ROA -60.0%
ROE -99.5%
ROIC -70.2%
Financial Health
Net Cash
$318.85K
Current Ratio 3.11
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insul...
Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Sep 23, 2021
Website www.xortx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove XRTX